Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Locally Recurrent Prostate Cancer

We are excited to bring the Alpha DaRT technology to prostate cancer patients in the U.S.,” said Dr. Robert B. Den, Alpha Tau ...
ascopubs.org

Defining Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy: A Proposal for a Standardized Definition

Prostate-specific antigen (PSA) defined biochemical recurrence (BCR) of prostate cancer is widely used for reporting the outcome of radical prostatectomy (RP). A standardized BCR definition is lacking ...
The New York Times

What a Prostate Cancer Diagnosis Like Biden’s Means for Patients

While prognoses for prostate cancer patients were once measured in months, experts say that advances in treatment and diagnosis now improve survival by years. By Gina Kolata Prostate cancer experts ...
The Scranton Times-Tribune

Early detection, constant communication key in dealing with prostate cancers

When a team of doctors diagnosed former President Joe Biden with an aggressive form of prostate cancer last month, it cast the most commonly occurring cancer among men into the national spotlight. But ...